Cordifolioside: Potent Inhibitor Against M of SARS-CoV-2 and Immunomodulatory Through Human TGF-β and TNF-α

Overview

Journal 3 Biotech

Publisher Springer

Specialty Biotechnology

Date 2021 Mar 1

PMID 33643762

Citations 5

Authors

Munikumar Manne

Giridhar Goudar

Seshadri Reddy Varikasuvu

Mahadev C Khetagoudar

Hema Kanipakam

Pradeep Natarajan

Muni Divya Ummiti

Vijay Aravind Yenagi

Sridhar Chinthakindi

Prakash Dharani

Durga Sai Sri Thota

Sameer Patil

Vijaylaxmi Patil

Affiliations

Soon will be listed here.

Abstract

Therapeutic options for SARS-CoV-2 are limited merely to the symptoms or repurposed drugs and non-specific interventions to promote the human immune system. In the present study, chromatographic and in silico approaches were implemented to identify bioactive compounds which might play pivotal role as inhibitor for SARS-CoV-2 and human immunomodulator (TGF-β and TNF-α). (Willd.) Miers was evaluated for phenolic composition and explored for bioactive compounds by high-performance thin layer chromatography (HPTLC). Furthermore, the bioactive compounds such as cordifolioside, berberine, and magnoflorine were appraised as human immunomodulatory and potent inhibitor against Main Protease (M) of SARS-CoV-2 through multiple docking strategies. Cordifolioside formed six stable H-bonds with His41, Ser144, Cys145, His163, His164, and Glu166 of M of SARS-CoV-2, which displayed a significant role in the viral replication/transcription during infection acting towards the common conserved binding cleft among all strains of coronavirus. Overall, the study emphasized that the proposed cordifolioside might use for future investigations, which hold as a promising scaffold for developing anti-COVID-19 drug and reduce human cytokine storm.

Citing Articles

Review: : A peculiar plant of .

Tian Y, Geng Y, Zhang Y, Zhao Z, Ruan L, Zhang C Open Life Sci. 2024; 19(1):20220963.

PMID: 39588115 PMC: 11588012. DOI: 10.1515/biol-2022-0963.

Plausibility of natural immunomodulators in the treatment of COVID-19-A comprehensive analysis and future recommendations.

Akter R, Rahman M, Ahmed Z, Afrose A Heliyon. 2023; 9(6):e17478.

PMID: 37366526 PMC: 10284624. DOI: 10.1016/j.heliyon.2023.e17478.

investigation of the role of vitamins in cancer therapy through inhibition of MCM7 oncoprotein.

Mukherjee S, Das S, Sriram N, Chakraborty S, Sah M RSC Adv. 2022; 12(48):31004-31015.

PMID: 36349041 PMC: 9619486. DOI: 10.1039/d2ra03703c.

Inhibition of the main protease of SARS-CoV-2 (M) by repurposing/designing drug-like substances and utilizing nature's toolbox of bioactive compounds.

Antonopoulou I, Sapountzaki E, Rova U, Christakopoulos P Comput Struct Biotechnol J. 2022; 20:1306-1344.

PMID: 35308802 PMC: 8920478. DOI: 10.1016/j.csbj.2022.03.009.

Assessment of Antioxidant, Immunomodulatory Activity of Oxidised Epigallocatechin-3-Gallate (Green Tea Polyphenol) and Its Action on the Main Protease of SARS-CoV-2-An In Vitro and In Silico Approach.

Ungarala R, Munikumar M, Sinha S, Kumar D, Sunder R, Challa S Antioxidants (Basel). 2022; 11(2).

PMID: 35204178 PMC: 8868081. DOI: 10.3390/antiox11020294.

References

Newman D, Cragg G . Natural Products as Sources of New Drugs from 1981 to 2014. J Nat Prod. 2016; 79(3):629-61. DOI: 10.1021/acs.jnatprod.5b01055. View

Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M . Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020; 30(3):269-271. PMC: 7054408. DOI: 10.1038/s41422-020-0282-0. View

Asres K, Seyoum A, Veeresham C, Bucar F, Gibbons S . Naturally derived anti-HIV agents. Phytother Res. 2005; 19(7):557-81. DOI: 10.1002/ptr.1629. View

Re R, Pellegrini N, Proteggente A, Pannala A, Yang M . Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic Biol Med. 1999; 26(9-10):1231-7. DOI: 10.1016/s0891-5849(98)00315-3. View

Ashok B, Ravishankar B, Prajapati P, Bhat S . Antipyretic activity of Guduchi Ghrita formulations in albino rats. Ayu. 2011; 31(3):367-70. PMC: 3221073. DOI: 10.4103/0974-8520.77162. View

Meyer-Almes F . Repurposing approved drugs as potential inhibitors of 3CL-protease of SARS-CoV-2: Virtual screening and structure based drug design. Comput Biol Chem. 2020; 88:107351. PMC: 7832737. DOI: 10.1016/j.compbiolchem.2020.107351. View

Chen J . Pathogenicity and transmissibility of 2019-nCoV-A quick overview and comparison with other emerging viruses. Microbes Infect. 2020; 22(2):69-71. PMC: 7102641. DOI: 10.1016/j.micinf.2020.01.004. View

Lin S, Ho C, Chuo W, Li S, Wang T, Lin C . Effective inhibition of MERS-CoV infection by resveratrol. BMC Infect Dis. 2017; 17(1):144. PMC: 5307780. DOI: 10.1186/s12879-017-2253-8. View

Killerby M, Biggs H, Haynes A, Dahl R, Mustaquim D, Gerber S . Human coronavirus circulation in the United States 2014-2017. J Clin Virol. 2018; 101:52-56. PMC: 7106380. DOI: 10.1016/j.jcv.2018.01.019. View

10.

Shree P, Mishra P, Selvaraj C, Singh S, Chaube R, Garg N . Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants - (Ashwagandha), (Giloy) and (Tulsi) - a molecular docking study. J Biomol Struct Dyn. 2020; 40(1):190-203. PMC: 7484581. DOI: 10.1080/07391102.2020.1810778. View

11.

Higgins D, Sharp P . CLUSTAL: a package for performing multiple sequence alignment on a microcomputer. Gene. 1988; 73(1):237-44. DOI: 10.1016/0378-1119(88)90330-7. View

12.

Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H . Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020; 130(5):2620-2629. PMC: 7190990. DOI: 10.1172/JCI137244. View

13.

Du J, He Z, Jiang R, Ye W, Xu H, But P . Antiviral flavonoids from the root bark of Morus alba L. Phytochemistry. 2003; 62(8):1235-8. DOI: 10.1016/s0031-9422(02)00753-7. View

14.

Liang J, Pitsillou E, Karagiannis C, Darmawan K, Ng K, Hung A . Interaction of the prototypical α-ketoamide inhibitor with the SARS-CoV-2 main protease active site in silico: Molecular dynamic simulations highlight the stability of the ligand-protein complex. Comput Biol Chem. 2020; 87:107292. PMC: 7253975. DOI: 10.1016/j.compbiolchem.2020.107292. View

15.

Hilgenfeld R . From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design. FEBS J. 2014; 281(18):4085-96. PMC: 7163996. DOI: 10.1111/febs.12936. View

16.

Pitsillou E, Liang J, Karagiannis C, Ververis K, Darmawan K, Ng K . Interaction of small molecules with the SARS-CoV-2 main protease in silico and in vitro validation of potential lead compounds using an enzyme-linked immunosorbent assay. Comput Biol Chem. 2020; 89:107408. PMC: 7583591. DOI: 10.1016/j.compbiolchem.2020.107408. View

17.

Shivananjappa M, Muralidhara . Abrogation of maternal and fetal oxidative stress in the streptozotocin-induced diabetic rat by dietary supplements of Tinospora cordifolia. Nutrition. 2011; 28(5):581-7. DOI: 10.1016/j.nut.2011.09.015. View

18.

Munikumar M, Krishna V, Seshadri Reddy V, Rajeswari B, Sriram D, Rao M . In silico design of small peptides antagonist against leptin receptor for the treatment of obesity and its associated immune-mediated diseases. J Mol Graph Model. 2018; 82:20-36. DOI: 10.1016/j.jmgm.2018.04.002. View

19.

OConnell J, Porter J, Kroeplien B, Norman T, Rapecki S, Davis R . Small molecules that inhibit TNF signalling by stabilising an asymmetric form of the trimer. Nat Commun. 2019; 10(1):5795. PMC: 6923382. DOI: 10.1038/s41467-019-13616-1. View

20.

Panchabhai T, Kulkarni U, Rege N . Validation of therapeutic claims of Tinospora cordifolia: a review. Phytother Res. 2008; 22(4):425-41. DOI: 10.1002/ptr.2347. View